Journal of Oncology

Journal of Oncology / 2021 / Article

Corrigendum | Open Access

Volume 2021 |Article ID 3735726 | https://doi.org/10.1155/2021/3735726

Bi-Cheng Wang, Bo-Ya Xiao, Peng-Cheng Li, Bo-Hua Kuang, Wang-Bing Chen, Pin-Dong Li, Guo-He Lin, Quentin Liu, "Corrigendum to “Efficacy and Safety of First-Line Immunotherapy in Combination with Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis”", Journal of Oncology, vol. 2021, Article ID 3735726, 1 page, 2021. https://doi.org/10.1155/2021/3735726

Corrigendum to “Efficacy and Safety of First-Line Immunotherapy in Combination with Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis”

Received17 Feb 2021
Accepted17 Feb 2021
Published26 Feb 2021

In the article titled “Efficacy and Safety of First-Line Immunotherapy in Combination with Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis” [1], the information was omitted in the Acknowledgments section: the Hubei Provincial Natural Science Foundation (grant number: 2020 to Bi-Cheng Wang). The corrected section appears as follows:

Acknowledgments

The authors thank the Bi-Cheng Wang studio for helping to offer ideas and improve grammar and spelling. This study was supported by the Independent Innovation Foundation of Wuhan Union Hospital (grant number: 2019-109 to Bi-Cheng Wang) and the Hubei Provincial Natural Science Foundation (grant number: 2020CFB397 to Bi-Cheng Wang).

References

  1. B.-C. Wang, B.-Y. Xiao, P.-C. Li et al., “Efficacy and Safety of First-Line Immunotherapy in Combination with Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis,” Journal of Oncology, vol. 2020, Article ID 2368164, 10 pages, 2020. View at: Publisher Site | Google Scholar

Copyright © 2021 Bi-Cheng Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views58
Downloads153
Citations

Related articles